SciBase Holding AB (publ) (STO:SCIB)

Market Cap	136.49M
Revenue (ttm)	36.59M
Net Income (ttm)	-90.39M
Shares Out	623.26M
EPS (ttm)	-0.29
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	460,931
Average Volume	512,515
Open	0.2100
Previous Close	0.2190
Day's Range	0.1850 - 0.2320
52-Week Range	0.1990 - 0.5980
Beta	0.62
RSI	32.32
Earnings Date	Feb 26, 2026

About SciBase Holding AB

SciBase Holding AB (publ), a medical technology company, develops and commercializes point-of-care platforms for skin health management in Europe, the United States, North America, Asia, Oceania, and internationally. It operates through Skin Cancer and Skin Barrier Assessment segments. The company offers Nevisense and Nevisense Go point-of-care platforms to detect melanoma and non-melanoma skin cancer; and for research within skin barrier assessment. It has a collaboration with Mayo Clinic on pigmented lesion digital workflows with AI-driven Ne...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1998
• Employees: 32
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SCIB

Financial Performance

In 2024, SciBase Holding AB's revenue was 29.71 million, an increase of 27.79% compared to the previous year's 23.25 million. Losses were -61.13 million, 9.97% more than in 2023.